GABA in plasma and cerebrospinal fluid of different species. Effects of γ‐acetylenic GABA, γ‐vinyl GABA and sodium valproate

THE POSSIBLE role of GABA as an inhibitory neurotransmitter in mammalian brain led to the speculation that changes in GABA levels in the CNS may be associated with certain neurological disorders. Decreased levels of GABA and of glutam am ate I-carboxylase (EC 4.1.1.15), the enzyme responsible for the synthesis of GABA, have been determined in postmortem brains from patients with Huntington’s chorea (BIRD et al., 1973; PERRY et al., 1973). More recently, it has been found that the amount of GABA in the CSF of choreic patients is significantly lower as compared to control subjects (GLAESER et al., 1975; ENNA er al., 19770). The latter observation and the existence of a concentration gradient for GABA within the ventriculospinal fluid system (ENNA et al., 1977b) suggest that CSF GABA may reflect brain GABA concentrations. The measurement of GABA in CSF may therefore be useful both as a diagnostic test for certain disorders and in studying drug effects on brain GABA levels. However, accurate measurement of the low concentrations of GABA in CSF still poses analytical problems and only few relatively complicated methods are available which are sensitive and specific enough for this purpose. Whereas with the help of such techniques as liquid chromatography, gas chromatography-mass spectrometry and a radioreceptor assay GABA has been determined in picomole quantities in CSF of humans (GLAESER & HARE, 1975; GLAESER et a[., 1975; ENNA et al., 1977a,h; HUIZINGA et al., 1977; BOHLEN et al., 1978; COLBY & MCCAMAN, 1978; WOOD et al., 197%) and rats (HUOT ef al., 1978), reports on CSF GABA concentrations in dogs (LOGOTHETIS, 1958) and cats (SNODGRASS er al., 1969) showed much higher values and probably reflect inadequacies of the methods used. More recently, GABA has also been detected in low concentrations in blood and plasma of different species including man (FERKANY et al., 1978; HUOT et ul., 1978). In the present study, the GABA concentrations in CSF and plasma of dog, cat and rat were determined and compared with those of man using the radioreceptor assay of ENNA et al. (19776). Furthermore, preliminary experiments on the effect of agents known to increase brain GABA on the concentration of this amino acid in CSF and plasma are reported

[1]  L. Iversen,et al.  Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea. , 1973, Lancet.

[2]  Solomon H. Snyder,et al.  Influences of Ions, Enzymes, and Detergents on γ-Aminobutyric Acid-Receptor Binding in Synaptic Membranes of Rat Brain , 1977 .

[3]  S. Enna,et al.  Verification and quantification of GABA in human cerebrospinal fluid , 1978, Journal of neurochemistry.

[4]  K. Elliott,et al.  DISPOSITION OF γ‐AMINOBUTYRIC ACID ADMINISTERED TO MAMMALS * , 1958 .

[5]  H. Davson,et al.  THE CONCENTRATIONS OF FREE AMINO ACIDS AND OTHER ELECTROLYTES IN CEREBROSPINAL FLUID, IN VIVO DIALYSATE OF BRAIN, AND BLOOD PLASMA OF THE DOG * , 1966, Journal of neurochemistry.

[6]  P. Schechter,et al.  Automated Assay of 'y-Aminobutyric Acid in Human Cerebrospinal Fluid , 1978 .

[7]  B. Metcalf,et al.  Catalytic inhibition of γ-aminobutyric acid-α-ketoglutarate transaminase of bacterial origin by 4-aminohex-5-ynoic acid, a substrate analog , 1975 .

[8]  W. Löscher,et al.  Distribution of valproate across the interface between blood and cerebrospinal fluid , 1978, Neuropharmacology.

[9]  M. McCaman,et al.  A highly specific and sensitive determination of gamma-aminobutyric acid by gas chromatography mass spectrometry. , 1978, Biomedical mass spectrometry.

[10]  J. Logothetis Free amino acid content of cerebrospinal fluid in humans and dogs , 1958, Neurology.

[11]  W. Löscher,et al.  Consecutive Gas Chromatographic Determination of Phenytoin, Phenobarbital, Primidone, Phenylethylmalondiamide, Carbamazepine, Trimethadione, Dimethadione, Ethosuximide, and Valproate from the Same Serum Specimen , 1978, Epilepsia.

[12]  A. Sjoerdsma,et al.  Antiseizure activity of gamma-acetylenic gamma-aminobutyric acid: a catalytic irreversible inhibitor of gamma-aminobutyric acid transaminase. , 1977, The Journal of pharmacology and experimental therapeutics.

[13]  T. Hare,et al.  Measurement of GABA in human cerebrospinal fluid. , 1975, Biochemical medicine.

[14]  P. Schechter,et al.  Automated assay of gamma-aminobutyric acid in human cerebrospinal fluid. , 1978, Clinical chemistry.

[15]  W. Lo¨scher 3-Mercaptopropionic acid: Convulsant properties, effects on enzymes of the γ-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine , 1979 .

[16]  S. Snyder,et al.  Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions , 1975, Brain Research.

[17]  W. Loscher,et al.  Identification of Metabolites of Valproic Acid in Serum of Humans, Dog, Rat, and Mouse , 1978, Epilepsia.

[18]  L. Fowler,et al.  An analysis of the kinetics of the inhibition of rabbit brain gamma-aminobutyrate aminotransferase by sodium n-dipropylacetate and some other simple carboxylic acids. , 1975, Biochemical pharmacology.

[19]  R. Olsen,et al.  Effects of drugs on γ-aminobutyric acid receptors, uptake, release and synthesis in vitro , 1978, Brain Research.

[20]  P. Mandel,et al.  Effect of sodium n-dipropylacetate on audiogenic seizures and brain -aminobutyric acid level. , 1973, Biochemical pharmacology.

[21]  W. Vogel,et al.  GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report. , 1975, Biochemical medicine.

[22]  J. vd Meulen,et al.  Identification of GABA in human CSF by gas liquid chromatography and mass spectrometry. , 1977, The New England journal of medicine.

[23]  W. Löscher,et al.  Pharmacokinetics of sodium valproate in dog and mouse. , 1978, Arzneimittel-Forschung.

[24]  S. Snyder,et al.  γ‐Aminobutyric acid (GABA) in human cerebrospinal fluid: radioreceptor assay , 1977, Journal of neurochemistry.

[25]  P. Schechter,et al.  Audiogenic seizure protection by elevated brain GABA concentration in mice: Effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors , 1977 .

[26]  J. Wood,et al.  Effect of L-cycloserine on brain GABA metabolism. , 1978, Canadian journal of physiology and pharmacology.

[27]  A. Young,et al.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Stern,et al.  Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders. , 1977, Archives of neurology.

[29]  R. Caprioli,et al.  Measurement of gamma-aminobutyric acid (GABA) in blood. , 1978, Life sciences.

[30]  B. Metcalf,et al.  4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. , 1977, European journal of biochemistry.

[31]  S. R. Snodgrass,et al.  Transport of neutral amino acids from feline cerebrospinal fluid. , 1969, American Journal of Physiology.

[32]  I. Pye,et al.  STUDIES OF THE INTER‐RELATIONSHIP BETWEEN CEREBROSPINAL FLUID AND PLASMA AMINO ACID CONCENTRATIONS IN NORMAL INDIVIDUALS , 1977, Journal of neurochemistry.

[33]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  P. Eymard,et al.  477 – EPILEPSIE EXPERIMENTALE A L'GUABAINE CHEZ LA SOURIS. MODE D'ACTION DE L'ACIDE VALPROIQUE , 1978 .

[35]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[36]  Philip D. Harvey,et al.  The inhibitory effect of sodium n‐dipropyl acetate on the degradative enzymes of the GABA shunt , 1975, FEBS letters.

[37]  Shirley Hansen,et al.  Huntington's Chorea , 1973 .